Biosimilar policy is the perfect example of what happens when the industry does not deliver constructively, with the government forced into policy responses like the disastrous 2023 catch-up statutory price reductions. …
The terrible events of 2023 were born of a decade-old policy failure
March 11, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
New technology hits Australia for type 1 diabetes patients
March 12, 2025 - - Latest News -
'What I love about this event is that it brings together a community of people who otherwise feel quite isolated'
March 11, 2025 - - Latest News -
The terrible events of 2023 were born of a decade-old policy failure
March 11, 2025 - - Latest News -
New report reveals scathing patient assessment of Pharmac's culture
March 11, 2025 - - Latest News -
The key is leading with good ideas that will make the system better
March 11, 2025 - - Latest News -
Total continues to grow as AstraZeneca and Alexion maintain lead
March 10, 2025 - - Latest News -
Anatara Lifesciences updates on GaRP-Irritable Bowel Syndrome trial
March 10, 2025 - - Australian Biotech